Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
SURMOUNT-2, which included participants with type 2 diabetes, showed weight reductions of 12.8% to 15.7% with tirzepatide versus 3.2% with placebo
This peptide binds to a specific receptor on the surface of beta cells in the pancreas, causing them to release insulin, and for a long time researchers assumed that GLP-1 analogues only affected insulin release, hence why they were prescribed for type 2 diabetes
Most Kaiser regions added the OSA pathway in 2026
(2013, March 17)
US$ 22.32
US$ 23.12
US$ 27.33
US$ 20.62
US$ 24.18
US$ 23.26
US$ 23.99
US$ 29.82
US$ 26.76
